Top Markets
#1 Black Phoenix Black Phoenix +357.53%
#2 Islamic Coin Islamic Coin +158.14%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +19.93%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#6 Victoria VR Victoria VR +7.35%
#7 Pons Pons +6.63%
#8 COTI COTI +6.01%
#9 Movement Movement +5.28%
#10 Palladium Network Palladium Network +5.16%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Classificação em ações #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Preço da ação
$0.0005
Última sincronização: 2026-08-11
Valor de mercado
$10.28K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar VIA Pharmaceuticals, Inc. (VIAP)

Categoria

Healthcare
Preço VIAP com a capitalização de mercado de B
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
VIAP
$0.0005
Capitalização de mercado de VIA Pharmaceuticals, Inc.(VIAP)
Valor de mercado: $10.28K
Em August 2026, VIA Pharmaceuticals, Inc. tem uma capitalização de mercado de $10.28K. Isso faz com que VIA Pharmaceuticals, Inc. seja a 41780th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de VIA Pharmaceuticals, Inc. de 2007 a 2026
VIAP comparado com o topo de 5 mais populares stocks
Preço para VIAP Ativo B Capitalização de mercado de B Resultados
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$261,862 $10.28K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +52,372,404,414.06%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$215,166 $10.28K
Apple Inc. Apple Inc.
AAPL
$4.423T +43,033,283,329.69%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$202,372 $10.28K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +40,474,456,550.28%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$178,194 $10.28K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +35,638,883,419.80%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$140,638 $10.28K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +28,127,529,770.61%